Published September 21, 2026 | Version v1

Repurposing Sorbifolin for Wound Recovery and Analgesia: Investigating its Therapuetic Potential in Adult Albino Wistar Rats

Description

Background: Wound healing and pain control are interconnected therapeutic challenges. Plant-derived flavonoids have attracted considerable interest because of their antioxidant and anti-inflammatory properties. Sorbifolin, a naturally occurring flavone, has demonstrated diverse biological activities; however, its wound-healing and analgesic effects remain comparatively underexplored. This study evaluated the wound-healing and analgesic activities of Sorbifolin in experimental rats. Methods: Acute oral toxicity was evaluated using an OECD acute toxic class-based protocol. Wound-healing activity was assessed using an approximately 500 mm² open excision wound model. Animals received control ointment, Sorbifolin, or 10% povidone-iodine, and wound area was measured on days 1, 4, 7, 10, 13, and 16. Epithelialization time was also determined. Analgesic activity was evaluated using tail-immersion and hot-plate methods, with normal saline as control and diclofenac sodium as the reference treatment. Results: Sorbifolin significantly enhanced wound contraction and reduced wound area compared with control. On day 16, wound area was 71 ± 3.7 mm² with Sorbifolin compared with 184 ± 9.8 mm² in control and 80 ± 5.8 mm² with povidone-iodine. Epithelialization occurred within 15.24 days with Sorbifolin versus 24.36 days in control. Sorbifolin produced 41.4% inhibition in the tail-immersion test and 56.83% inhibition in the hot-plate test, compared with 64.2% and 61.92%, respectively, for diclofenac. Conclusion: Sorbifolin demonstrated promising wound-healing and measurable analgesic activities, with wound-healing effects broadly comparable to povidone-iodine. Further mechanistic and dose-ranging studies are warranted.

Files

74-Dr. C. Radhika.pdf

Files (4.5 MB)

Name Size
md5:29a06ecc7eb52dc1b7fbd2a4e2663701
4.5 MB Preview Download